Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)	74.67%	73.38%	77.48%	76.93%	76.99%	72.72%	77.29%	78.06%	77.97%	78.66%	80.71%	81.68%	74.73%	81.78%	79.66%	81.82%	81.95%	68.47%	74.55%	79.51%
EBT Margin (Quarter)	-11.29%	-14.80%	25.84%	6.53%	-0.38%	-3.27%	9.52%	11.90%	7.17%	2.99%	16.27%	18.56%	18.03%	22.70%	31.95%	36.09%	-3.39%	-3.10%	18.43%	6.20%
EBIT Margin (Quarter)	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%	11.21%
EBITDA Margin (Quarter)	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%	11.21%
Operating Margin (Quarter)	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%	11.21%
Net Margin (Quarter)	-8.93%	-12.87%	23.26%	5.18%	-1.32%	-0.05%	8.53%	9.41%	6.95%	3.15%	13.66%	15.05%	14.22%	16.72%	24.92%	29.14%	-3.96%	-5.33%	13.77%	4.52%
FCF Margin (Quarter)	23.57%	1.11%	-14.30%	17.65%	31.92%	-23.50%	-16.50%	14.93%	12.64%	9.92%	3.22%	13.68%	27.22%	22.23%	21.15%	22.84%	41.21%	6.74%	26.07%	14.07%
Efficiency
Inventory Average (Quarter)	0.73B	0.76B	0.78B	0.79B	0.82B	0.87B	0.91B	0.95B	1.00B	1.07B	1.12B	1.16B	1.18B	1.21B	1.25B	1.31B	1.36B	1.34B	1.29B	1.53B
Assets Average (Quarter)	5.94B	5.99B	6.03B	6.10B	6.20B	6.32B	6.40B	6.50B	6.66B	6.80B	6.86B	6.97B	6.96B	6.92B	7.07B	7.30B	7.54B	7.60B	8.09B	10.16B
Invested Capital (Quarter)	0.05B	0.05B	0.06B	0.03B	0.03B	0.02B				0.49B	0.49B	0.49B								0.66B
Asset Utilization Ratio (Quarter)	0.31	0.31	0.31	0.31	0.32	0.33	0.34	0.34	0.35	0.36	0.36	0.37	0.40	0.41	0.42	0.42	0.41	0.42	0.40	0.34
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-13.75	-17.13	36.08	10.15	-0.52	-3.61	16.85	17.46	8.08	-53.49	24.53	33.38	36.40	62.63	78.20	72.14	-18.10	-36.54	7.45	1.74
Debt Ratio (Quarter)	0.01	0.01	0.01	0.00	0.00	0.00				0.07	0.07	0.07						0.08	0.17	0.41
Times Interest Earned (Quarter)	-13.75	-17.13	36.08	10.15	-0.52	-3.61	16.85	17.46	8.08	-53.49	24.53	33.38	36.40	62.63	78.20	72.14	-18.10	-36.54	7.45	1.74
Valuation
Enterprise Value (Quarter)	-1.08B	-1.01B	-1.06B	-1.11B	-1.27B	-1.29B	-1.15B	-1.17B	-1.13B	-1.07B	-1.05B	-1.22B	-0.93B	-1.14B	-1.27B	-1.43B	-1.48B	-1.56B	-2.22B	-0.87B
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-1.25%	-1.51%	0.54%	1.02%	1.90%	2.81%	1.48%	1.91%	2.64%	3.30%	3.67%	4.52%	5.61%	7.67%	9.62%	11.73%	9.14%	5.98%	4.32%	1.76%
Return on Invested Capital (Quarter)	0.00%	-0.01%	0.00%	0.00%	0.01%	0.01%	0.01%	0.02%	0.05%	0.01%	0.00%	0.00%	0.00%	0.00%	0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Datasets

Plans

Developers

Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Research Tools

Datasets

Plans

Developers

Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Create an account

Sign In

Reset Password